Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Imatinib with Bosentan and Sildenafil in PAH
NCT01392469Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of imatinib in pulmonary arterial hypertension (PAH), sponsored by Novartis. Started Apr 2011; status: completed.
02
Drugs
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01392469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392469.